Duquesne Family Office LLCDuquesne Family Office LLC

Institutional investor · Portfolio as of Q4 2025

Top Holdings62 positions

Checking export access…
Activity:

NATERA INC

2.5M$575.3M12.8%$98.78+131.92%
14 qtrssince 2022-Q3
Decreased
0
XLFXLF
ETF

SELECT SECTOR SPDR TR

5.5M$301M6.7%$55.18-0.82%
1 qtr
New
95

INSMED INC

1.5M$257.9M5.7%$88.13+97.47%
7 qtrssince 2024-Q2
Decreased
0
RSPRSP
ETF

INVESCO S&P 500 EQUAL WEIGHT ETF

1.2M$224.9M5.0%$189.300.00%
1 qtr
New
95
TEVATEVA
ADR

TEVA PHARMACEUTICAL INDS LTD

5.9M$183.4M4.1%$18.91+65.01%
6 qtrssince 2024-Q3
Decreased
0

WOODWARD INC

590,930$178.7M4.0%$149.59+101.58%
9 qtrssince 2023-Q4
Decreased
0

Amazon.com, Inc.

737,940$170.3M3.8%$226.39+2.71%
2 qtrssince 2025-Q3
Increased
83
TSMTSM
ADR

TAIWAN SEMICONDUCTOR MFG LTD

543,085$165M3.7%$178.70+68.73%
6 qtrssince 2024-Q3
Decreased
0

COUPANG INC CL A

6.8M$159.8M3.6%$30.64-23.01%
20 qtrssince 2021-Q1
Increased
76
EWZEWZ
CALL

ISHARES INC

4.2M$134.3M3.0%———
New
—

Alphabet Inc.

385,000$120.5M2.7%$293.83+6.32%
2 qtrssince 2025-Q3
Increased
83
SESE
ADR

SEA LTD SPONSORD ADS

944,120$120.4M2.7%$136.97-6.86%
3 qtrssince 2025-Q2
Increased
83
EWZEWZ
ETF

ISHARES INC

3.6M$112.9M2.5%$31.470.00%
1 qtr
New
78

NEWAMSTERDAM PHARMA COMPANY NV ORDINARY SHARES

3.1M$107.7M2.4%$28.37+23.64%
6 qtrssince 2024-Q3
Increased
74

Mercadolibre Inc

47,149$95M2.1%$1,785.15+12.83%
7 qtrssince 2024-Q2
Decreased
0

BBB FOODS INC CL A COM

2.7M$89.3M2.0%$30.65+8.93%
3 qtrssince 2025-Q2
Increased
76

RESTAURANT BRANDS INTL INC

1.2M$82.5M1.8%$63.09+5.28%
3 qtrssince 2025-Q2
Increased
50

COGENT BIOSCIENCES INC COM

2.2M$78.7M1.8%$26.12+18.68%
2 qtrssince 2025-Q3
Increased
76

ALCOA CORP

1.4M$73.1M1.6%$52.870.00%
1 qtr
New
68

Entegris Inc

844,160$71.1M1.6%$84.050.00%
1 qtr
New
68
$4.5B
AUM
62
Positions
Q4 2025
Filing
HI score · 1.5/5
Quarterly 13F Value Change
+1%Q3'24$2.9B+25%Q4'24$3.6B-16%Q1'25$3B+31%Q2'25$3.9B+0%Q3'25$3.9B+7%Q4'25$4.2B
Activity profile
$ moved · Q4'25
New39%Increased15%Decreased18%Exited27%
Composition
Equity vs derivatives
Equity94%Puts0%Calls6%
Holding period
Avg 2.1 years
<1Q26%1-4Q24%1-2Y16%2Y+34%

Duquesne Family Office LLC manages $4.5B across 62 positions as of Q4 2025. Top holdings: NTRA (12.8%), XLF (6.7%), INSM (5.7%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1.5/5.0.

Q4 2025 Summary

Active quarter - 26 new positions, 30 exits, 13 increased. Top move: XLF (NEW, conviction 95). Portfolio: $4.5B across 62 positions.

Top holdings by portfolio weight

Total AUM$4B
NTRA12.80%
XLF6.70%
INSM5.74%
RSP5.00%
TEVA4.08%
WWD3.97%
AMZN3.79%
TSM3.67%
CPNG3.55%
GOOGL2.68%
Other2.68%

Portfolio allocation by GICS sector

Sectors10
Healthcare30.77%
Consumer Cyclical16.38%
Unknown16.31%
Technology11.51%
Industrials10.31%
Communication Services5.56%
Basic Materials4.20%
Consumer Defensive2.37%
Financial Services2.08%
Energy0.52%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Healthcare, Consumer Cyclical, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L42
Conviction47
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
2Q
ADMAADMAADMA BIOLOGICS INC COM
Q1 2026 → Q2 2026+2.5M shares+$18.7M
2Q
CLFCLFCLEVELAND-CLIFFS INC NEW COM
Q1 2026 → Q2 2026+2.5M shares+$16.4M
2Q
NTRANTRANATERA INC
Q1 2026 → Q2 2026+674,949 shares+$289.6M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used